10-04 :: April 2010
several months and over 50% for the year, we are lucky there are many talented people in the valley looking for a high growth opportunity at this time,” said Lex Kosowsky, President and CEO.
Shocking Technologies, Inc. is a privately held, venture-backed company developing Voltage Swit- chable Dielectric™ (VSD™) materials. A VSD™ mate- rial is a polymer nano-composite that behaves like an insulator (dielectric) during normal circuit operation and becomes conductive when the voltage across the VSDTM material increases beyond a predefined threshold voltage. After the voltage drops below the threshold again, it switches back to an insulator.
hrink Nanotechnologies, Inc. (OTCBB: INKN), an innovative nanotechnology company deve-
loping products and licensing opportunities in the solar energy production, medical diagnostics, sensors and biotechnology research and development tools businesses, announced that FINRA has approved a common stock forward split of 5 for 1. For a period of 20 business days, the Company’s stock symbol will be “INKND.” On the 21st business day subsequent to the 15th of April, 2010, the Company’s stock symbol will revert back to its present stock symbol of “INKN.”
The forward split will be “payable upon surrender” of existing common stock to the Company’s transfer agent, Action Stock Transfer. Following the forward stock split, there will be approximately 191,303,985 issued and outstanding common shares. Shrink‘s products are based on a pre-stressed plastic called NanoShrink™, and on a patent-pending manufac- turing process called the ShrinkChip Manufacturing
Solution™. Furthermore, Shrink announced that its proprietary NanoShrink™ material has shown to produce superior microfluidic and point-of-care test prototypes in a landmark study conducted by the University of California Irvine‘s (UCI) Department of Biomedical Engineering, USA. The UCI findings were published in “Lab on a Chip”.
Diep Nguyen, Douglas Taylor, Kun Qian, Nizilla Norouzi, Jerald Rasmussen, Steve Botzet, Matt Lehmann, Kurt Hal- verson and Michelle Khine: Better shrinkage than Shrinky- Dinks, In: Lab Chip AOP, March 24, 2010, DOI:10.1039/ c001082k:
http://dx.doi.org/ 10.1039/c001082k http://www.shrinknano.com
loning, leading supplier of synthetic biology tools, was awarded US Patent No, 7,695,906. Sloning’s enabling platform technology – Slonomics®
researchers to increase the success rate of their scree- ning for new and optimized therapeutic antibodies, proteins or industrial enzymes.
Key to Sloning’s success is the company’s core tech- nology, Slonomics®
, a patented technology that uses
a set of double stranded DNA triplets as universal building blocks for the synthesis of combinatorial libraries – “one codon at a time”. For library produc- tion, multiple codons can be introduced in parallel at any desired sequence position. The absence of functional bias and the ability to select and precisely control delivery of up to 20 codons at any ratio re- sults in exceptionally high quality libraries containing the complete set of desired mutants. In addition, mutated regions of varying length can also be incor- porated in the design.